Patents Assigned to Atreca, Inc.
  • Publication number: 20240327505
    Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.
    Type: Application
    Filed: October 20, 2022
    Publication date: October 3, 2024
    Applicants: University of Vermont and State Agricultural College, Atreca, Inc.
    Inventors: Jason Botten, Katherine L. Williams, Ngan Nguyen Atkins, Annalis Whitaker
  • Publication number: 20240301038
    Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.
    Type: Application
    Filed: March 24, 2022
    Publication date: September 12, 2024
    Applicants: Atreca, Inc., University of Vermont and State Agricultural College
    Inventors: Katherine L. Williams, Daniel Eric Emerling, Shaun M. Lippow, Ngan Nguyen Atkins, Jason Botten, Annalis Whitaker
  • Publication number: 20230167169
    Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.
    Type: Application
    Filed: January 26, 2023
    Publication date: June 1, 2023
    Applicant: Atreca, Inc.
    Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
  • Patent number: 11655290
    Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: May 23, 2023
    Assignee: Atreca, Inc.
    Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
  • Publication number: 20230002483
    Abstract: The present disclosure provides anti-circumsporozoite (CSP) antibodies, compositions comprising such antibodies. Also disclosed are methods of producing the disclosed antibodies and methods of treating or preventing malaria using the same.
    Type: Application
    Filed: June 16, 2022
    Publication date: January 5, 2023
    Applicant: Atreca, Inc.
    Inventors: Daniel Eric Emerling, Randal R. Ketchem, Shaun M. Lippow, Wayne Volkmuth, Katherine L. Williams
  • Publication number: 20220389471
    Abstract: Provided herein are methods and compositions for analyzing nucleic acids associated with single cells using nucleic acid barcodes. According to some embodiments, a method for producing one or more polynucleotides of interest comprises: obtaining a plurality of RNAs associated with one or more samples, wherein the samples are obtained from one or more subjects, each RNA is associated with a single sample, and the RNAs associated with each sample are present in a separate reaction volume; adding an adapter molecule to the RNAs associated with each sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and incorporating the barcode sequence into one or more polynucleotides associated with each sample, thereby producing the one or more polynucleotides of interest.
    Type: Application
    Filed: June 17, 2022
    Publication date: December 8, 2022
    Applicants: Atreca, Inc., Atreca, Inc.
    Inventors: Yann Chong TAN, Gary WITHEY
  • Patent number: 11472885
    Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: October 18, 2022
    Assignee: Atreca, Inc.
    Inventors: Jeff DeFalco, Daniel Eric Emerling, Jessica Finn, Norman Michael Greenberg, Vera Huang, Shaun M. Lippow, Fengling Liu, Amy Manning-Bog, William H. Robinson, Alexander Scholz, Tito Serafini, Yann Chong Tan, Nikhil Vad, Wayne Volkmuth
  • Patent number: 11098304
    Abstract: Provided herein are methods of identifying the origin of a nucleic acid sample. The methods include forming a reaction mixture comprising a nucleic acid sample comprising nucleic acid molecules from a single cell and a set of barcodes, incorporating the set of barcodes into the nucleic acid molecules of the sample, and identifying the set of barcodes incorporated into the nucleic acid molecules of the single cell thereby identifying the origin of the nucleic acid sample.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: August 24, 2021
    Assignee: ATRECA, INC.
    Inventor: Gary Withey
  • Patent number: 11066464
    Abstract: Antibodies that bind to the circumsporozoite protein (CSP) of Plasmodium falciparum. Use of such antibodies as anti-malarial agents, to confer protection against infection by malarial parasites such as P. falciparum by insect vector transmission. Diagnosis of malaria using anti-CSP antibodies. Methods of determining efficacy of candidate vaccine compositions in development and testing of anti-malarial vaccines.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: July 20, 2021
    Assignees: KYMAB LIMITED, ATRECA, INC.
    Inventors: Qi Liang, Sean Matthew Carroll, Daniel Eric Emerling, Allan Bradley, Paul Kellam, {hacek over (S)}pela Binter, Simon James Watson
  • Patent number: 10620219
    Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: April 14, 2020
    Assignee: ATRECA, INC.
    Inventors: Jeff DeFalco, Daniel Emerling, Shaun Lippow, Sean Carroll, Wayne Volkmuth, Norm Greenberg, Tito Serafini
  • Patent number: 10316345
    Abstract: Provided herein are methods and compositions for analyzing nucleic acids associated with single cells using nucleic acid barcodes. According to some embodiments, a method for producing one or more polynucleotides of interest comprises: obtaining a plurality of RNAs associated with one or more samples, wherein the samples are obtained from one or more subjects, each RNA is associated with a single sample, and the RNAs associated with each sample are present in a separate reaction volume; adding an adapter molecule to the RNAs associated with each sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and incorporating the barcode sequence into one or more polynucleotides associated with each sample, thereby producing the one or more polynucleotides of interest.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: June 11, 2019
    Assignee: ATRECA, INC.
    Inventors: Yann Chong Tan, Gary Withey
  • Publication number: 20180362628
    Abstract: Antibodies that bind to the circumsporozoite protein (CSP) of Plasmodium falciparum. Use of such antibodies as anti-malarial agents, to confer protection against infection by malarial parasites such as P. falciparum by insect vector transmission. Diagnosis of malaria using anti-CSP antibodies. Methods of determining efficacy of candidate vaccine compositions in development and testing of anti-malarial vaccines.
    Type: Application
    Filed: May 11, 2018
    Publication date: December 20, 2018
    Applicants: KYMAB LIMITED, ATRECA, INC.
    Inventors: Qi Liang, Sean Matthew Carroll, Daniel Eric Emerling, Allan Bradley, Paul Kellam, Spela Binter, Simon James Watson
  • Patent number: 9834766
    Abstract: The present disclosure provides methods for optimizing barcode design for multiplex DNA sequencing. Also disclosed are DNA barcodes optimized for use with particular sequencing technologies.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: December 5, 2017
    Assignee: Atreca, Inc.
    Inventors: Wayne Volkmuth, Yann Chong Tan
  • Patent number: 9580736
    Abstract: Provided herein are methods and compositions for analyzing nucleic acids associated with single cells using nucleic acid barcodes. According to some embodiments, a method for producing one or more polynucleotides of interest comprises: obtaining a plurality of RNAs associated with one or more samples, wherein the samples are obtained from one or more subjects, each RNA is associated with a single sample, and the RNAs associated with each sample are present in a separate reaction volume; adding an adapter molecule to the RNAs associated with each sample, wherein the adapter molecule is generated using an enzymatic reaction and comprises a universal priming sequence, a barcode sequence, and a binding site; and incorporating the barcode sequence into one or more polynucleotides associated with each sample, thereby producing the one or more polynucleotides of interest.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: February 28, 2017
    Assignee: Atreca, Inc.
    Inventors: Yann Chong Tan, Gary Withey
  • Publication number: 20150080266
    Abstract: The present disclosure provides methods for optimizing barcode design for multiplex DNA sequencing. Also disclosed are DNA barcodes optimized for use with particular sequencing technologies.
    Type: Application
    Filed: September 4, 2012
    Publication date: March 19, 2015
    Applicant: Atreca, Inc.
    Inventors: Wayne Volkmuth, Yann Chong Tan